Skip to content

Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model

Evaluation of the Anticaries Efficacy of Various Dentifrice Formulations Using an In-situ Model

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06140758
Enrollment
12
Registered
2023-11-20
Start date
2023-07-31
Completion date
2023-12-11
Last updated
2024-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries

Brief summary

The primary objective is to compare the remineralization and demineralization inhibition potential of early subsurface carious lesions in enamel in situ after rinsing with six different aqueous slurries of toothpaste formulations.

Interventions

DRUGOral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate) Dentifrice

Each subject will use this product during one of the six treatment periods in the crossover study design.

DRUGColgate 1450 ppm Fluoride (1.16% sodium monofluorophosphate)Dentifrice

Each subject will use this product during one of the six treatment periods in the crossover study design.

DRUGToms of Maine 0 ppm Fluoride Dentifrice

Each subject will use this product during one of the six treatment periods in the crossover study design.

DRUGColgate 1450 ppm Fluoride (1.1% sodium monofluorophosphate) Dentifrice

Each subject will use this product during one of the six treatment periods in the crossover study design.

DRUG1500 ppm MFP/CaCO3 1.16% sodium monofluorophosphate) Dentifrice

Each subject will use this product during one of the six treatment periods in the crossover study design.

DRUG1100 ppm (0.454% Stannous fluoride) Dentifrice

Each subject will use this product during one of the six treatment periods in the crossover study design.

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Be 18-75 years of age. * Provide written informed consent prior to participation and be given a signed copy of the informed consent form. * Be in good general health based on medical/dental history and oral exam. * Have no history of adverse or allergic reactions to tin or tin-containing products. * Agree not to participate in any other oral study for the study duration. * Have a reasonable functional dentition as determined by the oral examiner and sufficient teeth to support the fabricated dental appliance. * Be willing to participate in the study, able to follow the study directions, successfully tolerate/perform all study procedures, and willing to return for all specified visits at their appointed time. * Be willing to refrain from using non-study dentifrice, mouth rinse, chewing gum, and other non-study oral care products during the study. * Be willing to postpone all elective dental procedures until the study has been completed. * Be willing to refrain from using calcium chews while using the test products. * Be willing and able to refrain from wearing a nightguard (occlusal splint) for the entire course of the study (for nightguard wearers only). * Ability to understand, and ability to read and sign, the informed consent form. * Have at least 22 natural teeth. * Have a gum-stimulated whole salivary flow rate ≥ 1.0 ml/minute and unstimulated whole salivary flow rate ≥ 0.2 ml/minute.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Mineral Density14 daysThe percent mineral profile of each enamel/dentinel slab's demineralized control and remineralized/treated lesion, obtained from the microdensitometry analysis, will be compared with the median sound enamel percent mineral profile of the same section. A negative value indicates mineral has been lost and, therefore, the lesion has progressed, whereas a positive value indicates mineral has been gained and, therefore, the lesion has regressed.
Scanning Electron Microscopy (SEM)14 daysSEM imaging and SEM-EDS analysis will be conducted on TMR sections and whole sections of dentine lesions treated in situ to assess the occlusion of dentine tubules and distribution of elements within the lesions following the experiment.

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026